This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: retinopathy

November 2008 Br J Cardiol 2008;15:301

News from the EASD

Abstract

DIRECT results suggest increased regression of retinopathy in type 2 diabetes Three studies of the effect of candesartan on diabetic retinopathy produced mixed results in the first large-scale programme assessing the effect of an angiotensin receptor blocker on the incidence and progression of eye complications in patients with diabetes. The primary end points in the three DIabetic REtinopathy Candesartan Trials (DIRECT) were just missed. But investigators and independent clinicians argued the data were strong enough to influence clinical practice in secondary care although were insufficient to support a licence change. Professor Anthony Barn

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now